Publicaciones en colaboración con investigadores/as de Azienda Ospedaliero-Universitaria Careggi (30)

2024

  1. Prevalence and characteristics of transthyretin amyloid cardiomyopathy in hypertrophic cardiomyopathy

    ESC Heart Failure

2023

  1. Phase 2 Study of Aficamten in Patients With Obstructive Hypertrophic Cardiomyopathy

    Journal of the American College of Cardiology, Vol. 81, Núm. 1, pp. 34-45

  2. Rest and Stress Left Atrial Dysfunction in Patients with Atrial Fibrillation

    Journal of Clinical Medicine, Vol. 12, Núm. 18

  3. von Willebrand factor neutralizing and non-neutralizing alloantibodies in 213 subjects with type 3 von Willebrand disease enrolled in 3WINTERS-IPS

    Journal of Thrombosis and Haemostasis, Vol. 21, Núm. 4, pp. 787-799

2022

  1. Clinical Features and Natural History of Preadolescent Nonsyndromic Hypertrophic Cardiomyopathy

    Journal of the American College of Cardiology, Vol. 79, Núm. 20, pp. 1986-1997

  2. Impact of SARS-Cov-2 infection in patients with hypertrophic cardiomyopathy: results of an international multicentre registry

    ESC Heart Failure, Vol. 9, Núm. 4, pp. 2189-2198

  3. Left atrial volume changes during exercise stress echocardiography in heart failure and hypertrophic cardiomyopathy

    Hellenic Journal of Cardiology, Vol. 67, pp. 9-18

  4. Pulmonary congestion during Exercise stress Echocardiography in Hypertrophic Cardiomyopathy

    International Journal of Cardiovascular Imaging

  5. The role of the electrocardiographic phenotype in risk stratification for sudden cardiac death in childhood hypertrophic cardiomyopathy

    European Journal of Preventive Cardiology, Vol. 29, Núm. 4, pp. 645-653

  6. Von Willebrand factor propeptide and pathophysiological mechanisms in European and Iranian patients with type 3 von Willebrand disease enrolled in the 3WINTERS-IPS study

    Journal of Thrombosis and Haemostasis, Vol. 20, Núm. 5, pp. 1106-1114

2021

  1. Aortic valve replacement: validation of the Toronto Aortic Stenosis Quality of Life Questionnaire

    ESC Heart Failure, Vol. 8, Núm. 1, pp. 270-279

  2. Appropriateness for SARS-CoV-2 vaccination for otolaryngologist and head and neck surgeons in case of pregnancy, breastfeeding, or childbearing potential: Yo-IFOS and CEORL-HNS joint clinical consensus statement

    European Archives of Oto-Rhino-Laryngology, Vol. 278, Núm. 10, pp. 4091-4099

  3. Cardiac Involvement in Fabry Disease: JACC Review Topic of the Week

    Journal of the American College of Cardiology, Vol. 77, Núm. 7, pp. 922-936

  4. Differences between familial and sporadic dilated cardiomyopathy: ESC EORP Cardiomyopathy & Myocarditis registry

    ESC Heart Failure, Vol. 8, Núm. 1, pp. 95-105

  5. Feasibility and functional correlates of left atrial volume changes during stress echocardiography in chronic coronary syndromes

    International Journal of Cardiovascular Imaging, Vol. 37, Núm. 3, pp. 953-964

  6. Prognostic value of reduced heart rate reserve during exercise in hypertrophic cardiomyopathy

    Journal of Clinical Medicine, Vol. 10, Núm. 7

  7. Quality of life after transcatheter or surgical aortic valve replacement using the Toronto Aortic Stenosis Quality of Life Questionnaire

    Open Heart, Vol. 8, Núm. 2

  8. Stress echo 2030: The novel ABCDE-(FGLPR) protocol to define the future of imaging

    Journal of Clinical Medicine, Vol. 10, Núm. 16

2020

  1. Bleeding symptoms in patients diagnosed as type 3 von Willebrand disease: Results from 3WINTERS-IPS, an international and collaborative cross-sectional study

    Journal of Thrombosis and Haemostasis, Vol. 18, Núm. 9, pp. 2145-2154

  2. Clinical Features and Natural History of PRKAG2 Variant Cardiac Glycogenosis

    Journal of the American College of Cardiology, Vol. 76, Núm. 2, pp. 186-197